AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Detailed analysis of the humoral immune response to a protective vaccine

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 1-10

  Mazzetti, Paola ^a   Giannecchini, Simone ^a   Del Mauro, Daniela ^a   Matteucci, Donatella ^a   Portincasa, Pietro ^b   Merico, Antonio ^a   Chezzi, Carlo ^b   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; RNA DIRECTED DNA POLYMERASE; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; LYMPHOBLAST; LYMPHOID CELL LINE; NONHUMAN; PRIORITY JOURNAL; SERUM; T LYMPHOCYTE; VACCINATION; VIRUS NEUTRALIZATION;

EID: 0032888953     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.1-10.1999     Document Type: Article

References (16)

1. Ahmad, A., and J. Menezes. 1996. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J. 10:258-266.
2. Almond, N., J. Rose, R. Sangster, P. Silvera, R. Stebbings, B. Walker, and E. J. Stott. 1997. Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. J. Gen. Virol. 78:1919-1922.
3. Avrameas, A., J.-G. Guillet, L. Chouchane, A. Moraillon, P. Sonigo, and A. D. Strosberg. 1992. Localization of three epitopes of the env protein of feline immunodeficiency virus. Mol. Immunol. 29:565-572.
4. Baldinotti, F., D. Matteucci, P. Mazzetti, C. Giannelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68:4572-4579.
5. Binley, J. M., H. Arshad, T. R. Fouls, and J. P. Moore. 1997. An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 13:1007-1015.
6. Bishop, S. A., C. R. Stokes, T. J. Gruffydd-Jones, C. V. Whiting, J. E. Humphries, R. Osborne, M. Papanastasopoulou, and D. A. Harbour. 1996. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response. Vaccine 14:1243-1250.
7. Broström, C., A. Sönnerborg, and M. Sällberg. 1995. Human immunodeficiency virus type 1-infected patients with no disease progression display high-avidity antibody production to autologous V3 sequences. J. Infect. Dis. 171:509-511.
8. Bucci, J. G., R. V. English, H. L. Jordan, T. A. Childers, M. B. Tompkins, and W. A. F. Tompkins. 1998. Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus. J. Infect. Dis. 177:18-25.
9. Burton, D. R. 1997. A vaccine for HIV type 1: the antibody perspective. Proc. Natl. Acad. Sci. USA 94:10018-10023.
10. Cairns, J. S., and M. P. D'Souza. 1998. Chemokines and HIV-1 second receptors: the therapeutic connection. Nat. Med. 4:563-568.
11. Chargelegue, D., C. M. Stanley, C. M. O'Toole, B. T. Colvin, and M. W. Steward. 1995. The absence or loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1 infected patients. J. Infect. Dis. 172:897.
12. Clements, J. E., R. C. Montelaro, M. C. Zink, A. M. Amedee, S. Miller, A. M. Trichel, B. Jagerski, D. Hauer, L. N. Martin, R. P. Bohm, and M. Murphey-Corb. 1995. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69:2737-2744.
13. Cole, K. S., J. L. Rowles, B. A. Jagerski, M. Murphey-Corb, T. Unangst, J. E. Clements, J. Robinson, M. S. Wyand, R. C. Desrosiers, and R. C. Montelaro. 1997. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J. Virol. 71:5069-5079.
14. Del Mauro, D., D. Matteucci, S. Giannecchini, F. Maggi, M. Pistello, and M. Bendinelli. 1998. Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates. J. Virol. 72:2199-2207.
15. De Ronde, A. J., J. G. Stam, P. Boers, H. Langedijk, R. Meloen, W. Hesselink, L. C. E. J. M. Keldermans, A. van Vliet, E. J. Verschoor, M. C. Horzinek, and H. F. Egberink. 1994. Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 198:257-264.
16. De Thé, G. 1996. Roundtable: can experience with veterinary retroviral vaccines be applied to the human situation? AIDS Res. Hum. Retroviruses 12:365-373.